The Kerala High Court on Wednesday sought expert opinions from four institutions on whether a cheaper off-patent breast cancer drug can be used as a substitute for a costlier patented alternative, even as it examined whether patients can be denied access to life-saving treatment because of the high cost of patented medicines | India News

Kerala High Court requests reports on potential substitutes for costly cancer drugs Ribociclib and Palbociclib amid affordability concerns.

The Kerala High Court on Wednesday sought expert opinions from four institutions on whether a cheaper off-patent breast cancer drug can be used as a substitute for a costlier…